Hrt Financial LP Ligand Pharmaceuticals Inc Transaction History

Hrt Financial LP

  • $17 Billion
  • Q2 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$68.64 - $89.2 $2.15 Million - $2.79 Million
31,266 New
31,266 $2.29 Million
Q1 2023

May 12, 2023
SELL
$65.67 - $77.08 $1.48 Million - $1.74 Million
-22,548 Reduced 71.76%
8,872 $652,000
Q4 2022

Feb 10, 2023
BUY
$61.72 - $96.74 $1.12 Million - $1.75 Million
18,115 Added 136.15%
31,420 $2.1 Million
Q3 2022

Nov 14, 2022
BUY
$0.01 - $107.56 $133 - $1.43 Million
13,305 New
13,305 $1.15 Million
Q1 2022

May 16, 2022
SELL
$94.99 - $151.56 $958,259 - $1.53 Million
-10,088 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$127.69 - $165.85 $1.29 Million - $1.67 Million
10,088 New
10,088 $1.56 Million
Q2 2021

Aug 16, 2021
SELL
$113.03 - $155.64 $1.07 Million - $1.47 Million
-9,472 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$99.52 - $215.83 $942,653 - $2.04 Million
9,472 New
9,472 $1.44 Million
Q3 2020

Nov 13, 2020
SELL
$89.56 - $126.72 $202,047 - $285,880
-2,256 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$68.28 - $123.65 $154,039 - $278,954
2,256 New
2,256 $252,000
Q4 2019

Feb 14, 2020
SELL
$96.94 - $113.59 $203,089 - $237,971
-2,095 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$86.25 - $120.16 $416,242 - $579,892
-4,826 Reduced 69.73%
2,095 $208,000
Q2 2019

Aug 14, 2019
BUY
$107.38 - $129.34 $743,176 - $895,162
6,921 New
6,921 $790,000

Others Institutions Holding LGND

# of Institutions
247
Shares Held
17.5M
Call Options Held
61K
Put Options Held
7.8K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.69B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email